Illness	Number of cases
Malignant neoplasm of prostate (C61)	416
Hyperplasia of prostate (N40)	205
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	181
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	181
Calculus of kidney and ureter - Calculus of ureter (N20.1)	143
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	129
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5)	114
Calculus of kidney and ureter - Calculus of kidney (N20.0)	66
Obstructive and reflux uropathy (N13.3)	54
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1)	49

Top 10 treatments

Treatment	Number
Use of an imaging procedure during an operation (3-992)	694
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	664
Injection or administration of medicines into the urinary bladder (8-132.3)	622
Insertion, exchange or removal of a ureteral stent (8-137.10)	399
Computed tomography (CT) of the abdomen without contrast medium (3-207)	361
Insertion, exchange or removal of a ureteral stent (8-137.00)	322
(1-465.91)	288
Ultrasound of the male reproductive organs with access through the urethra or anus (3-05c.0)	269
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	182
Computed tomography of the abdomen with contrast medium (3-225)	161

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
52	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
43	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
36	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Lectureships / teaching posts at colleges and universities